BIOTOSCANA INVESTMENTS S.A
Corporate Taxpayer’s ID (CNPJ/ME): 19,688,956/0001-56
L-1470 Luxembourg, 70 route d’Esch, Grand-Duché de Luxembourg
Legal representative in Brazil: Av. dos Imarés, 401, São Paulo, SP

NOTICE TO THE MARKET
1Q20 RESULTS RELEASE DATE

BIOTOSCANA INVESTMENTS S.A. (“Company” or “GBT”) (B3: GBIO33), a leading biopharmaceutical company in Latin America, hereby informs that, in the current context of the COVID-19 pandemic, it intends to release the quarterly results regarding the first quarter of 2020 on June 26 , 2020, pursuant to the CVM Deliberation n.o 849, of March 31, 2020.

The Calendar of Events is also available in the Company’s IR website.

Montevideo, May 28, 2020

BIOTOSCANA INVESTMENTS S.A.
Claudio Coracini
Representante Legal in Brasil

Updated on 05/29/2020 at 01:04 pm